Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Senti Bio Awarded $8 Million Grant from California Institute for Regenerative Medicines for Clinical Development of Logic Gated CAR-NK Cell Therapy

Jul 01, 2024

Contract Type

partnership

South San FranciscoBiotechnology

Description

Senti Biosciences, Inc. (Nasdaq: SNTI) has announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to support the ongoing clinical development of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural killer (CAR-NK) investigational cell therapy for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia.

Company Information

Company

Senti Biosciences

Location

South San Francisco, California, United States

About

Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.

Related People

Faraz
Likely contact at this company
••••••••@••••••••

See Faraz's verified email →

Faraz
Senior decision-maker at this company
••••••••@••••••••

See Faraz's verified email →

Thomas
Senior decision-maker at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Senti Biosciences's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Senti Biosciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.